Feb 25, 2025 / 10:30PM GMT
Joseph Fridman - Ginkgo Bioworks Holdings Inc - Director of Communications and Corporate Affairs
Good evening. I'm Joseph Fridman, Director of Communications and Corporate Affairs here at Ginkgo, where it's my fifth year. During that time, I've had the pleasure and the privilege of working with our Investor Relations team, usually behind the scenes of these earnings calls. And so it's exciting to be supporting you today in this more front-facing role.
I'm joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO. Thanks, as always, for joining us. We're really looking forward to updating you on our progress today.
As a reminder, during the presentation today, we will be making forward-looking statements. These involve risks and uncertainties. So please refer to our filings with the SEC to learn more about these risks and uncertainties, including in our most recent 10-K.
Today, in addition to updating you on the quarter and the full-year results, we're going to provide updates on our path towards adjusted EBITDA breakeven, as well as customer progress in our cell
Q4 2024 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
Feb 26, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers